Sign In
Buy FATE
$2.22
-0.350 (-13.62%)
At Close: Jun 03, 2026
Fate Therapeutics Inc (NASDAQ:FATE) Expected to Announce Quarterly Sales of $2.07 Million
05:08am, Wednesday, 15'th Apr 2020
Wall Street brokerages forecast that Fate Therapeutics Inc (NASDAQ:FATE) will report $2.07 million in sales for the current fiscal quarter, according to Zacks Investment Research. Seven analysts have
Top Ranked Momentum Stocks to Buy for April 14th
01:13pm, Tuesday, 14'th Apr 2020
Top Ranked Momentum Stocks to Buy for April 14th
Top Ranked Momentum Stocks to Buy for April 14th
01:13pm, Tuesday, 14'th Apr 2020
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, April 14th
Fate Therapeutics (NASDAQ:FATE) Raised to "Buy" at BidaskClub
10:20am, Tuesday, 14'th Apr 2020
Fate Therapeutics (NASDAQ:FATE) was upgraded by BidaskClub from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Tuesday, BidAskClub reports. Other res
Atara Biotherapeutics: Still Bullish On Long-Term Prospects
04:43am, Tuesday, 14'th Apr 2020
Atara Biotherapeutics recently updated that its lead program, tab-cel, remains on track despite the COVID-19 pandemic. Tab-cel is the most advanced allogeneic T
Fate Therapeutics (NASDAQ:FATE) Cut to "Hold" at Zacks Investment Research
11:58am, Sunday, 12'th Apr 2020
Zacks Investment Research downgraded shares of Fate Therapeutics (NASDAQ:FATE) from a buy rating to a hold rating in a research report released on Thursday, Zacks.com reports. According to Zacks, “F
AQR Capital Management LLC Has $374,000 Stock Holdings in Fate Therapeutics Inc (NASDAQ:FATE)
08:52am, Sunday, 12'th Apr 2020
AQR Capital Management LLC cut its holdings in Fate Therapeutics Inc (NASDAQ:FATE) by 35.5% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 19,086 shares of th
Fate Therapeutics (FATE) is a Great Momentum Stock: Should You Buy?
04:00pm, Friday, 10'th Apr 2020
Does Fate Therapeutics (FATE) have what it takes to be a top stock pick for momentum investors? Let's find out.
Fate Therapeutics (FATE) is a Great Momentum Stock: Should You Buy?
04:00pm, Friday, 10'th Apr 2020
Does Fate Therapeutics (FATE) have what it takes to be a top stock pick for momentum investors? Let's find out.
Investment Analysts' Weekly Ratings Changes for Fate Therapeutics (FATE)
07:56am, Friday, 10'th Apr 2020
Fate Therapeutics (NASDAQ: FATE) has recently received a number of price target changes and ratings updates: 4/9/2020 – Fate Therapeutics was downgraded by analysts at Zacks Investment Research from
Why Fate Therapeutics Tumbled 23.9% in March
12:59pm, Thursday, 09'th Apr 2020
The development-stage pharma company gave up a good chunk of its gains from recent months, but roared back in April.
Q2 2020 Earnings Forecast for Fate Therapeutics Inc (NASDAQ:FATE) Issued By Oppenheimer
06:02am, Thursday, 09'th Apr 2020
Fate Therapeutics Inc (NASDAQ:FATE) – Investment analysts at Oppenheimer boosted their Q2 2020 earnings per share (EPS) estimates for shares of Fate Therapeutics in a research note issued on Sunday,
Is Fate Therapeutics (FATE) Stock Outpacing Its Medical Peers This Year?
03:30pm, Wednesday, 08'th Apr 2020
Is (FATE) Outperforming Other Medical Stocks This Year?
Is Fate Therapeutics (FATE) Stock Outpacing Its Medical Peers This Year?
03:30pm, Wednesday, 08'th Apr 2020
Is (FATE) Outperforming Other Medical Stocks This Year?
